Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells
出版年份 2015 全文链接
标题
Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 16, Issue 11, Pages 27228-27251
出版商
MDPI AG
发表日期
2015-11-13
DOI
10.3390/ijms161126018
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Maintenance chemotherapy in the management of epithelial ovarian cancer
- (2015) Maurie Markman CANCER AND METASTASIS REVIEWS
- Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions
- (2015) Avi Ashkenazi JOURNAL OF CLINICAL INVESTIGATION
- Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation
- (2015) Ching-Yi Liu et al. Oncotarget
- Aurora Kinase Inhibitor PHA-739358 Suppresses Growth of Hepatocellular Carcinoma In Vitro and in a Xenograft Mouse Model
- (2015) Daniel Benten et al. NEOPLASIA
- Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study
- (2014) P. Schoffski et al. ANNALS OF ONCOLOGY
- “Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?
- (2014) Alison Davis et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System
- (2014) W. Ruprecht Wiedemeyer et al. Frontiers in Oncology
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) J. A. Ledermann et al. ANNALS OF ONCOLOGY
- An international assessment of ovarian cancer incidence and mortality
- (2013) Kimberly A. Lowe et al. GYNECOLOGIC ONCOLOGY
- Flow cytometry based assays for the measurement of apoptosis-associated mitochondrial membrane depolarisation and cytochrome c release
- (2013) Melinda E. Christensen et al. METHODS
- Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models
- (2013) S. Xu et al. MOLECULAR CANCER THERAPEUTICS
- Development of PI3K inhibitors: lessons learned from early clinical trials
- (2013) Jordi Rodon et al. Nature Reviews Clinical Oncology
- Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion
- (2013) T-V Do et al. ONCOGENE
- Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
- (2013) Jiri Polivka et al. PHARMACOLOGY & THERAPEUTICS
- Optimal first-line treatment in ovarian cancer
- (2012) F. A. Raja et al. ANNALS OF ONCOLOGY
- Akt Inhibitors MK-2206 and Nelfinavir Overcome mTOR Inhibitor Resistance in Diffuse Large B-cell Lymphoma
- (2012) A. M. Petrich et al. CLINICAL CANCER RESEARCH
- Combination of an Allosteric Akt Inhibitor MK-2206 with Etoposide or Rapamycin Enhances the Antitumor Growth Effect in Neuroblastoma
- (2012) Z. Li et al. CLINICAL CANCER RESEARCH
- p21WAF1 and tumourigenesis
- (2012) Noel A. Warfel et al. CURRENT OPINION IN ONCOLOGY
- Danusertib, an aurora kinase inhibitor
- (2012) Hielke J Meulenbeld et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Aurora kinase inhibitors: Progress towards the clinic
- (2012) Madhu Kollareddy et al. INVESTIGATIONAL NEW DRUGS
- Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors
- (2011) Lifang Xie et al. BIOCHEMICAL PHARMACOLOGY
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
- (2011) Piyush B. Gupta et al. CELL
- Cell death by autophagy: facts and apparent artefacts
- (2011) D Denton et al. CELL DEATH AND DIFFERENTIATION
- Cdc2: a monopotent or pluripotent CDK?
- (2011) X. Hu et al. CELL PROLIFERATION
- The dual role of autophagy in cancer
- (2011) Eeva-Liisa Eskelinen CURRENT OPINION IN PHARMACOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Rapamycin passes the torch: a new generation of mTOR inhibitors
- (2011) Don Benjamin et al. NATURE REVIEWS DRUG DISCOVERY
- Aurora kinase inhibitors as anti-cancer therapy
- (2010) Warren Lok et al. ANTI-CANCER DRUGS
- Apoptosis promotes early tumorigenesis
- (2010) D Tang et al. ONCOGENE
- Epithelial–Mesenchymal Transition: From Molecular Mechanisms, Redox Regulation to Implications in Human Health and Disease
- (2009) Stefania Cannito et al. ANTIOXIDANTS & REDOX SIGNALING
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Autophagy in the Pathogenesis of Disease
- (2008) Beth Levine et al. CELL
- Aurora Kinases as Anticancer Drug Targets
- (2008) O. Gautschi et al. CLINICAL CANCER RESEARCH
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- Apoptosis: controlled demolition at the cellular level
- (2007) Rebecca C. Taylor et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now